Purpose
to conduct preclinical research for the development of vaccine for Group B Streptococcus (GBS), benefitting communities in low-middle income settings where the burden of invasive GBS disease is greatest
Grantee
Division
Global Health
Date
OCTOBER 2015
Region served
AFRICA,
EUROPE
Committed amount
$498,002
Grant topic
Pneumonia
Duration (months)
46
Grantee location
Parktown, Gauteng, South Africa
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.